Abiopharma

New Form 424B2 - JPMORGAN CHASE & CO <b>Filed:</b> 2026-06-02 <b>AccNo:</b> 0001213900-26-063966 <b>Size:</b> 2 MB

Clinical trial NCT07528508: status: NOT_YET_RECRUITING → RECRUITING.

New Form 424B2 - BANK OF AMERICA CORP /DE/ <b>Filed:</b> 2026-06-02 <b>AccNo:</b> 0001918704-26-015147 <b>Size:</b> 852 KB

Clinical trial NCT05787587: status: RECRUITING → ACTIVE_NOT_RECRUITING.

Clinical trial NCT05145400 updates: 1. completion date: 2031-03-01 → 2033-05-28 2. primary completion date: 2026-03-01 → 2033-05-28

Clinical trial NCT06290232 updates: 1. status: NOT_YET_RECRUITING → WITHDRAWN 2. start date: 2024-12-01 → 2026-12-01 3. enrollment: 20 → 0 participants 4. enrollment type: ESTIMATED → ACTUAL

Clinical trial NCT07481708 updates: 1. status: ACTIVE_NOT_RECRUITING → COMPLETED 2. enrollment type: ESTIMATED → ACTUAL

Clinical trial NCT05500222: enrollment: 700 → 845 participants.

Clinical trial NCT04487756 updates: 1. status: ACTIVE_NOT_RECRUITING → COMPLETED 2. completion date: 2024-10-01 → 2025-09-08 3. primary completion date: 2024-08-01 → 2025-09-08 4. enrollment type: ESTIMATED → ACTUAL

Clinical trial NCT04239703 updates: 1. completion date: 2027-12-01 → 2029-12-01 2. primary completion date: 2026-12-01 → 2028-12-01

Clinical trial NCT07570069: status: NOT_YET_RECRUITING → RECRUITING.

Clinical trial NCT06953934 updates: 1. status: NOT_YET_RECRUITING → RECRUITING 2. start date: 2025-10-14 → 2026-05-04 3. completion date: 2026-02-01 → 2026-09-01 4. primary completion date: 2026-02-01 → 2026-09-01

Clinical trial NCT06834360 updates: 1. status: RECRUITING → ACTIVE_NOT_RECRUITING 2. completion date: 2027-12-13 → 2027-10-11 3. primary completion date: 2027-01-08 → 2026-11-06 4. enrollment: 210 → 216 participants 5. enrollment type: ESTIMATED → ACTUAL

Clinical trial NCT05521126: completion date: 2026-06-01 → 2026-08-01.

Clinical trial NCT07580599 updates: 1. start date: 2024-12-03 → 2024-12-10 2. completion date: 2026-01-01 → 2025-05-01 3. primary completion date: 2025-11-10 → 2025-05-01